Injectable Poly-l-Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open-Label Study (FACES)

2012 ◽  
Vol 38 (7pt2) ◽  
pp. 1193-1205 ◽  
Author(s):  
Benjamin Bassichis ◽  
Gary Blick ◽  
Marcus Conant ◽  
David Condoluci ◽  
Michael Echavez ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Lactic Acid ◽  
Interim Analysis ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Immunodeficiency Virus ◽  
Facial Lipoatrophy

A Randomized, Multicenter, Open-Label Study of Poly-L-Lactic Acid for HIV-1 Facial Lipoatrophy

2007 ◽  
Vol 46 (5) ◽  
pp. 581-589 ◽  
Author(s):  
Dianne L Carey ◽  
David Baker ◽  
Gary D Rogers ◽  
Kathy Petoumenos ◽  
John Chuah ◽  
...  
Keyword(s):  
Lactic Acid ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Facial Lipoatrophy ◽  
Hiv 1

scholarly journals Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC

2019 ◽  
Vol 30 ◽  
pp. ix161-ix162
Author(s):  
F. De Marinis ◽  
K.K. Laktionov ◽  
A. Poltoratskiy ◽  
I. Egorova ◽  
M. Hochmair ◽  
...  
Keyword(s):  
Interim Analysis ◽  
Egfr Mutation ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Phase Iiib ◽  
Egfr Tki
Sign in / Sign up

Export Citation Format

Share Document